GlassScriptPhysician profile
Annette West
NPI 1659318780
$8,007.96
in general payments reported to CMS, 2019-2025
26 companies · $1,494 in 2025
The $1,494 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $288 · 2022: $963 · 2023: $2,061 · 2024: $3,201 · 2025: $1,494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,987 · Travel and Lodging: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,986.90 |
| Travel and Lodging | $769.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $2,290.75 | 2021-2025 | Titan, Genesis |
| Axonics, INC. | $1,958.81 | 2023-2024 | Axonics, Bulkamid |
| Antares Pharma, INC. | $1,335.00 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Boston Scientific Corporation | $644.24 | 2021-2025 | Watchman Flx, Avvigo Guidance System, Obsidio |
| Halozyme INC | $295.44 | 2023 | |
| Abbott Laboratories | $192.31 | 2021-2023 | Ensite Precision |
| Medtronic, INC. | $183.85 | 2023-2024 | Interstim |
| Sumitomo Pharma America, INC. | $183.08 | 2023-2025 | Gemtesa |
| Endo Pharmaceuticals INC. | $163.13 | 2023-2024 | Xiaflex, Aveed |
| Edap Technomed INC | $125.00 | 2023 | |
| Astellas Pharma US INC | $119.09 | 2022-2024 | Xtandi |
| Innovation Technologies INC | $84.38 | 2024 | Irrisept |
| Progenics Pharmaceuticals, INC. | $63.41 | 2024-2025 | |
| Endo USA, INC. | $42.08 | 2025 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $41.40 | 2023-2024 | Jelmyto |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $40.76 | 2025 | Tlando |
| Blue Earth Diagnostics | $36.55 | 2025 | Posluma |
| Abiomed | $35.19 | 2022 | |
| Cardiva Medical, INC. | $27.55 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Ethicon US, LLC | $24.82 | 2023 | Megadyne |
| Myriad Genetic Laboratories, INC. | $22.78 | 2023 | Myrisk |
| Hollister Incorporated | $21.70 | 2022 | |
| Janssen Biotech, INC. | $20.67 | 2023 | Akeega, Erleada |
| Procept Biorobotics Corporation | $20.64 | 2025 | |
| Pfizer INC. | $20.52 | 2024 | |
| Angiodynamics, INC. | $14.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.